KYORIN Pharmaceutical Co.,Ltd. (4569) Stock Statistics & Valuation Metrics

KYORIN Pharmaceutical Co.,Ltd. has a market cap or net worth of JPY 58.22B. The enterprise value is JPY 72.70B.

Market Cap

JPY 58.22B

Enterprise Value

JPY 72.70B

KYORIN Pharmaceutical Co.,Ltd. has 59,945,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

59,945,640

Owned by Insiders

―

Owned by Institutions

10.18%

KYORIN Pharmaceutical Co.,Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.63%.

Return on Equity (ROE)

0.02

Return on Assets (ROA)

0.02

Return on Invested Capital (ROIC)

1.63%

Return on Capital Employed (ROCE)

0.02

Revenue Per Employee

63.70M

Profits Per Employee

1.74M

Employee Count

1,982

Asset Turnover

0.65

Inventory Turnover

1.10

The current PE Ratio of KYORIN Pharmaceutical Co.,Ltd. is 29.37. KYORIN Pharmaceutical Co.,Ltd.’s PEG ratio is -0.37.

PE Ratio

29.37

PS Ratio

0.51

PB Ratio

0.45

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

-0.37

In the last 12 months, KYORIN Pharmaceutical Co.,Ltd. had revenue of 126.26B and earned 3.45B in profits. Earnings per share was 60.02.

Revenue

126.26B

Gross Profit

51.61B

Operating Income

3.57B

Pretax Income

4.45B

Net Income

3.45B

EBITDA

8.22B

Earnings Per Share (EPS)

60.02

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

KYORIN Pharmaceutical Co.,Ltd. pays an annual dividend of JPY 10.00, resulting in a dividend yield of 4.25%

Dividend Per Share

JPY 10.00

Dividend Yield

4.25%

Payout Ratio

76.63%

Free Cash Flow Yield

0.00%

Earnings Yield

3.42%

Beta

0.48

52-Week Price Change

-21.28%

50-Day Moving Average

1111.73

200-Day Moving Average

1323.73

Relative Strength Index (RSI)

50.52

Average Volume (3m)

225.37K

KYORIN Pharmaceutical Co.,Ltd. upcoming earnings date is Nov 09, 2026, TBA (Not Confirmed).

Last Earnings Date

Jul 30, 2026

Next Earnings Date

Nov 09, 2026

Ex-Dividend Date

Sep 29, 2026

KYORIN Pharmaceutical Co.,Ltd. as a current ratio of 4.60, with Debt / Equity ratio of 16.70%

Current Ratio

4.60

Quick Ratio

2.29

Debt to Market Cap

0.25

Net Debt to EBITDA

1.46

Interest Coverage Ratio

14.04

In the past 12 months, KYORIN Pharmaceutical Co.,Ltd. has paid 1.00B in taxes.

Income Tax

1.00B

Effective Tax Rate

0.23

KYORIN Pharmaceutical Co.,Ltd. EV to EBITDA ratio is 10.71, with an EV/FCF ratio of 0.00.

EV to Sales

0.58

EV to EBITDA

10.71

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

KYORIN Pharmaceutical Co.,Ltd. has JPY 16.95B in cash and marketable securities with JPY 23.24B in debt, giving a net cash position of -JPY 6.29B billion.

Cash & Marketable Securities

JPY 16.95B

Total Debt

JPY 23.24B

Net Cash

-JPY 6.29B

Net Cash Per Share

-JPY 104.90

Tangible Book Value Per Share

JPY 2,374.65

Gross margin is 40.21%, with operating margin of 1.72%, and net profit margin of 1.73%.

Gross Margin

40.21%

Operating Margin

1.72%

Pretax Margin

2.32%

Net Profit Margin

1.73%

EBITDA Margin

5.43%

EBIT Margin

1.72%

The average price target for KYORIN Pharmaceutical Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-4.71%

EPS Growth Forecast

-78.91%

Smart Score

―

AI Score

52